BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8913775)

  • 1. Alloantigen presentation to naive CD8+ T cells by mouse microglia: evidence for a distinct phenotype based on expression of surface-associated and soluble costimulatory molecules.
    Askew D; Walker WS
    Glia; 1996 Oct; 18(2):118-28. PubMed ID: 8913775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloantigen presentation by individual clones of mouse splenic macrophages. Selective expression of IL-1 alpha in response to CD8+ T cell-derived IFN-gamma defines the alloantigen-presenting phenotype.
    McCormack JM; Askew D; Walker WS
    J Immunol; 1993 Nov; 151(10):5218-27. PubMed ID: 8228220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse microglial cell lines differing in constitutive and interferon-gamma-inducible antigen-presenting activities for naive and memory CD4+ and CD8+ T cells.
    Walker WS; Gatewood J; Olivas E; Askew D; Havenith CE
    J Neuroimmunol; 1995 Dec; 63(2):163-74. PubMed ID: 8550814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse resident microglia: isolation and characterization of immunoregulatory properties with naïve CD4+ and CD8+ T-cells.
    Havenith CE; Askew D; Walker WS
    Glia; 1998 Apr; 22(4):348-59. PubMed ID: 9517567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiated regulation of allo-antigen presentation by different types of murine microglial cell lines.
    Kanzawa T; Sawada M; Kato K; Yamamoto K; Mori H; Tanaka R
    J Neurosci Res; 2000 Nov; 62(3):383-8. PubMed ID: 11054807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypes and alloantigen-presenting activity of individual clones of microglia derived from the mouse brain.
    Moore SC; McCormack JM; Armendariz E; Gatewood J; Walker WS
    J Neuroimmunol; 1992 Dec; 41(2):203-14. PubMed ID: 1469080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen.
    Curtsinger JM; Lins DC; Mescher MF
    J Immunol; 1998 Apr; 160(7):3236-43. PubMed ID: 9531279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell immunity induced by allogeneic microglia in relation to neuronal retina transplantation.
    Ma N; Streilein JW
    J Immunol; 1999 Apr; 162(8):4482-9. PubMed ID: 10201985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal costimulatory requirements for T cell priming and TH1 differentiation: activation of naive human T lymphocytes by tumor cells armed with bifunctional antibody constructs.
    Kufer P; Zettl F; Borschert K; Lutterbüse R; Kischel R; Riethmüller G
    Cancer Immun; 2001 Nov; 1():10. PubMed ID: 12747771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recently primed CD8+ T cells entering the liver induce hepatocytes to interact with naïve CD8+ T cells in the mouse.
    Dikopoulos N; Wegenka U; Kröger A; Hauser H; Schirmbeck R; Reimann J
    Hepatology; 2004 May; 39(5):1256-66. PubMed ID: 15122754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.
    Sugiura K; Kato K; Hashimoto F; Jin T; Amoh Y; Yamamoto Y; Morita H; Okumura K; Ikehara S
    Immunobiology; 1997 Nov; 197(5):460-77. PubMed ID: 9413746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-thyroid epithelial cell (TEC)-reactive CD8+ T cell lines/clones derived from autoimmune thyroiditis lesions. They recognize self-thyroid antigens directly on TEC to exhibit T helper cell 1-type lymphokine production and cytotoxicity against TEC.
    Sugihara S; Fujiwara H; Niimi H; Shearer GM
    J Immunol; 1995 Aug; 155(3):1619-28. PubMed ID: 7543527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones.
    Koide J; Engleman EG
    J Immunol; 1990 Jan; 144(1):32-40. PubMed ID: 1967266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.
    Klyushnenkova E; Mosca JD; Zernetkina V; Majumdar MK; Beggs KJ; Simonetti DW; Deans RJ; McIntosh KR
    J Biomed Sci; 2005; 12(1):47-57. PubMed ID: 15864738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of microglia by CD4+ and CD8+ T cells: selective analysis in CD45-congenic normal and Toxoplasma gondii-infected bone marrow chimeras.
    Schlüter D; Meyer T; Strack A; Reiter S; Kretschmar M; Wiestler OD; Hof H; Deckert M
    Brain Pathol; 2001 Jan; 11(1):44-55. PubMed ID: 11145203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-presenting function of human endothelial cells. Direct activation of resting CD8 T cells.
    Epperson DE; Pober JS
    J Immunol; 1994 Dec; 153(12):5402-12. PubMed ID: 7989746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.